1. Steinberg W, Tenner S.Acute pancreatitis. N Engl J Med1994;330:1198–210.
2.
2. McKay CJ, Imrie CW, Baxter JN. Sandostatin and sandostatin analogues—are they indicated in the management of acute pancreatitis?Gut1993;34:1622–6.
3.
3. Buchler M, Friess H, Klempa I, et al.Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg1992;163:125–31.
4.
4. Banks PA. Practice guidelines in acute pancreatitis. Am J Gastroenterol1997;92:377–86.
5.
5. Klein S, Kinney J, Jeejeebhoy K, et al.Nutrition support in clinical practice: review of published data and recommendations for future research directions. JPEN1997;21:133–56.
6.
6. Van Der Hulst RRWJ, Von Meyenfeldt MF, Tiebosch A, et al.Glutamine and intestinal immune cells in humans. JPEN1997;21:310–5.
7.
7. Beluzzi A, Brignola C, Campieri M, et al.Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med1996;334:1557–60.
8.
8. Loeschke K, Uebershaer B, Pietsch A, et al.N-3 Fatty acids only delay early relapse of ulcerative colitis in remission. Dig Dis Sci1996;41:2087–94.
9.
9. Scheppach W, Sommer H, Kirchmer T, et al.Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology1992;103:51–6.
10.
10. Mosdell KW, Visconti JA. Emerging indications for octreotide therapy, part 2. Am J Hosp Pharm1994;51:1317–30.
11.
11. Harris AG. Octreotide in the treatment of disorders of the gastrointestinal tract. Drug Invest1992;4:1–54.
12.
12. Prinz RA, Pickleman J, Hoffman JP. Treatment of pancreatic cutaneous fistulas with a somatostatin analog. Am J Surg1988;155:36–42.
13.
13. Sancho JJ, DiCostanzo J, Nubiola P, et al.Randomized double blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula. Br J Surg1995;82:638–41.
14.
14. Ritchie DJ, Holstad SG, Westrich TJ, et al.Activity of octreotide acetate in a total nutrient admixture. Am J Hosp Pharm1991;48:2172–5.
15.
15. O'Keefe SJ, Peterson ME, Fleming CR. Octreotide as an adjunct to home parenteral nutrition in the management of permanent end-jejunostomy syndrome. JPEN1994;18:26–34.
16.
16. Howard L, Ament M, Fleming CR, et al.Current use and clinical outcome of home parenteral and enteral nutrition therapies in the United States. Gastroenterology1995;109:355–65.
17.
17. Vand Der Hulst RRW, Van Kreel BK, et al.Glutamine and the preservation of gut integrity. Lancet1993;341:1363–5.
18.
18. Wilmore DW, Byrne TA, Persinger RL, et al.A new treatment for patients with short bowel syndrome: growth hormone, glutamine and a modified diet. Ann Surg1995;222:243–55.
19.
19. Wilmore DW, Lacey JM, Soultamakis RP, et al.Factors predicting a successful outcome after pharmacologic bowel compensation. Ann Surg1997;226:288–93.
